EMA Lapsed: Leflunomide Teva (leflunomide) — Teva Pharma B.V.

View source ↗

Summary

EMA status shows Leflunomide Teva (leflunomide) has lapsed its authorization in the European market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Leflunomide Teva (leflunomide)

Snippet

Status: Lapsed. Therapeutic area: Arthritis, Rheumatoid. MAH: Teva Pharma B.V.. Decision date: 15/01/2014